62135-973 : Mefloquine Hydrochloride 250 mg Oral Tablet
| NDC: | 62135-973 |
| Labeler: | Chartwell Rx, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: | Mefloquine Hydrochloride |
| Dosage Form: | Oral Tablet |
| Application #: | ANDA076175 |
| Rev. Date: |
NDC Package Codes:
- 62135-973-11: 5 TABLET IN 1 BOTTLE (62135‑973‑11)
- 62135-973-25: 25 TABLET IN 1 BOTTLE (62135‑973‑25)
Active Ingredients:
- Mefloquine Hydrochloride
Dosage Strength:
- 250 mg
Pharmaceutical Classes:
- Antimalarial [EPC]
Related Products:
Based on records with the same trade name.- 0054-0025 Mefloquine Hydrochloride 250 mg Oral Tablet by Roxane Laboratories, Inc.
- 0143-1282 Mefloquine Hydrochloride 250 mg Oral Tablet by West-ward Pharmaceutical Corp
- 0555-0171 Mefloquine Hydrochloride 250 mg Oral Tablet by Barr Laboratories Inc.
- 0781-5076 Mefloquine Hydrochloride 250 mg Oral Tablet by Sandoz Inc
- 21695-449 Mefloquine Hydrochloride 250 mg Oral Tablet by Rebel Distributors Corp
- 21695-561 Mefloquine Hydrochloride 250 mg Oral Tablet by Rebel Distributors Corp
- 50090-2396 Mefloquine Hydrochloride 250 mg Oral Tablet by A-s Medication Solutions
- 52959-803 Mefloquine Hydrochloride 250 mg Oral Tablet by H.j. Harkins Company, Inc.
- 54569-6661 Mefloquine Hydrochloride 250 mg Oral Tablet by A-s Medication Solutions
- 54868-5434 Mefloquine Hydrochloride 250 mg Oral Tablet by Physicians Total Care, Inc.
- 68071-4702 Mefloquine Hydrochloride 250 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
- 68788-6833 Mefloquine Hydrochloride 250 mg Oral Tablet by Preferred Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 62135-969Next: 62135-975 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.